Mental Effort During Low Load Resistance Training in Older Adults

July 6, 2026 updated by: Garrett Hester, Kennesaw State University

The Effect of Maximal Mental Effort During Resistance Training on Physical Function and Motor Unit Behavior in Older Adults

The goal of this clinical trial is to determine the effect of maximal mental effort combined with low-intensity resistance training on strength and neuromuscular function in older adults. The main questions it aims to answer are:

  • Does low-intensity resistance training in combination with maximal mental effort increase strength more than low intensity resistance training alone?
  • Does low-intensity resistance training in combination with maximal mental effort improve neuromuscular function more than low intensity resistance training alone?

Participants will be randomly assigned to 1 of 3 groups:

  • Low intensity resistance training
  • Low intensity resistance training with maximal mental effort
  • Control Researchers will compare groups to determine differences in changes in strength, neuromuscular function, and body composition.

Study Overview

Detailed Description

Participants in both training groups will perform 8 weeks of low intensity, whole-body resistance training. Participants in the control group will participate in all testing procedures but not perform any training. Participants from all groups will be instructed to otherwise maintain their normal physical activity levels and dietary habits.

All training sessions will be supervised by research personnel at a Kennesaw State University fitness center. Participants will complete 2 training sessions per week for 8 weeks. Each training session will last about 45-60 minutes and consist of 5 exercises, including both multi-joint (leg press, chest press, back row) and single-joint (knee extension, bicep curl) exercises. Participants will perform 2 sets of 15 repetitions for each exercise for the first 2 weeks, then volume will be increased by progressing to 3 sets for the remaining 6 weeks. There will be a 60-second rest interval between sets and a similar tempo will be used between groups.

Both training groups will perform the same training protocol, but participants in the maximal mental effort group will mentally urge their muscles to contract maximally during each repetition. That is, despite using a low intensity, participants will imagine the feeling of maximal muscle contraction of the primary muscles during each repetition.

Several measures of strength, neuromuscular function, physical function, and body composition will be measured before and after the training or control period.

Study Type

Interventional

Enrollment (Estimated)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Garrett Hester Professor of Exercise Science
  • Phone Number: 470-578-4267
  • Email: ghester4@kennesaw.edu

Study Locations

    • Georgia
      • Kennesaw, Georgia, United States, 30144
        • Recruiting
        • Kennesaw State University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body mass index between 18.5 - 33 kg·m2
  • No structured physical activity in past 2 years
  • Any unstable condition contradicting exercise
  • Independently walk with or without assistive device
  • No significant cognitive impairment

Exclusion Criteria:

  • Score of 22 or lower on Montreal Cognitive Assessment
  • Missing more than 3 training sessions (training groups only)
  • Pacemaker
  • Unstable angina
  • Symptomatic heart failure
  • Uncontrolled arrythmias
  • Uncontrolled hypertension (greater or equal to 160/90)
  • Myocardial infarction in the past 6 months
  • Uncontrolled type 2 diabetes
  • Type 1 diabetes
  • Severe or unstable pulmonary conditions,
  • Currently on supplemental oxygen therapy
  • Severe hearing loss or visual impairment
  • Alzheimer's Disease or significant cognitive impairment
  • Stroke in the past 6 months or ongoing stroke-induced motor impairment
  • Any neurological (e.g., Parkinson's) condition affecting motor control
  • Undergoing chemotherapy
  • Surgery in past 6 months
  • Musculoskeletal injury in the past 6 months
  • Terminal illness
  • Stage 3 or greater chronic kidney disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
This group will not perform any training and maintain their regular level of physical activity.
Experimental: Low Intensity Resistance Training
This group will perform low intensity, whole-body resistance training.
This training intervention will be 8 weeks of low intensity resistance training, including whole-body and isolated muscle exercises.
Experimental: Low Intensity Resistance Training with Maximal Mental Effort
This group will perform low intensity, whole-body resistance training with maximal mental effort during muscle contraction.
This training intervention will be 8 weeks of low intensity resistance training, including whole-body and isolated muscle exercises, where participants will perform maximal mental effort by imagining maximal muscle contraction during each exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in isokinetic strength of the knee extensors at 60 degrees per second
Time Frame: Baseline, Week 8
Dynamic strength of the knee extensors contracting at a constant velocity
Baseline, Week 8

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in isokinetic knee extensor muscle activation as measured by electromyography amplitude
Time Frame: Baseline, Week 8
Electromyography root mean square during isokinetic contraction divided by root mean square during isometric contraction
Baseline, Week 8
Change in isometric knee extensor strength as measured by newton-meters of torque
Time Frame: Baseline, Week 8
Isometric strength of a muscle
Baseline, Week 8
Change in knee extensor muscle activation as measured by electromyography amplitude
Time Frame: Baseline, Week 8
A measure of the capacity at which the muscle is activated by the nervous system
Baseline, Week 8
Change in motor unit firing rate as measured relative to the motor unit recruitment threshold
Time Frame: Baseline, Week 8
A measure of how nervous system input produces force output during an isometric contraction
Baseline, Week 8
Change in motor unit action potential size as measured relative to the motor unit recruitment threshold
Time Frame: Baseline, Week 8
A measure of how nervous system input produces force output during an isometric contraction
Baseline, Week 8
Change in handgrip strength as measured in kilograms of force
Time Frame: Baseline, Week 8
Upper-body strength as measured by a handgrip dynamometer
Baseline, Week 8
Change in walking speed as measured by time taken to walk 4 meters
Time Frame: Baseline, Week 8
Measure of lower-body physical function
Baseline, Week 8
Change in chair rise performance as measured by number of chair rises performed in 30 seconds
Time Frame: Baseline, Week 8
Measure of lower-body physical function
Baseline, Week 8
Change in bicep curl strength as measured by load lifted in pounds
Time Frame: Baseline, Week 8
Maximum dumbbell load lifted successfully throughout the range of motion of a bicep curl
Baseline, Week 8
Change in dynamic strength of the lower body muscles during the leg press as measured by load lifted in pounds for 5 repetitions
Time Frame: Baseline, Week 5, Week 8
Measure of dynamic strength during the leg press exercise
Baseline, Week 5, Week 8
Change in muscle composition as measured by ultrasound-derived grey-scale analysis
Time Frame: Baseline, Week 8
Echo-intensity value derived from grey-scale analysis is indicative of amount of non-contractile tissue in muscle
Baseline, Week 8
Change in skeletal muscle size as measured by ultrasound-derived cross-sectional area
Time Frame: Baseline, Week 8
Size of a muscle
Baseline, Week 8
Change in fat mass as measured by kilograms
Time Frame: Baseline, Week 8
Amount of fat tissue a person possesses estimated by bioelectrical impedance analysis
Baseline, Week 8
Change in fat-free mass as measured by kilograms
Time Frame: Baseline, Week 8
Amount of non-fat tissue a person possesses estimated by bioelectrical impedance analysis
Baseline, Week 8
Change in body fat percentage as measured by fat tissue relative to fat-free tissue
Time Frame: Baseline, Week 8
Relative amount of body fat a person possesses estimated by bioelectrical impedance analysis
Baseline, Week 8
Change in cognitive function as measured by the Montreal Cognitive Assessment
Time Frame: Baseline, Week 8
Assessment of cognitive function where 0 is the lowest score and 30 is the highest score and a higher score represents higher cognitive function.
Baseline, Week 8

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Study Registration Dates

First Submitted

June 30, 2026

First Submitted That Met QC Criteria

June 30, 2026

First Posted (Actual)

July 7, 2026

Study Record Updates

Last Update Posted (Actual)

July 8, 2026

Last Update Submitted That Met QC Criteria

July 6, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Clinical Trials on Low Intensity Resistance Training

3
Subscribe